Chee M. Ng

2.1k total citations
57 papers, 1.7k citations indexed

About

Chee M. Ng is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Chee M. Ng has authored 57 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 18 papers in Radiology, Nuclear Medicine and Imaging and 13 papers in Oncology. Recurrent topics in Chee M. Ng's work include Monoclonal and Polyclonal Antibodies Research (16 papers), Glycosylation and Glycoproteins Research (8 papers) and Prenatal Substance Exposure Effects (5 papers). Chee M. Ng is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (16 papers), Glycosylation and Glycoproteins Research (8 papers) and Prenatal Substance Exposure Effects (5 papers). Chee M. Ng collaborates with scholars based in United States, Switzerland and Germany. Chee M. Ng's co-authors include Robert J. Bauer, Deni Hardiansyah, Serge Guzy, René Bruno, Dan Combs, Brian E. Davies, Bert L. Lum, Paul J. Fielder, Kim L. R. Brouwer and Dhiren R. Thakker and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Chee M. Ng

56 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chee M. Ng United States	23	503	481	401	291	239	57	1.7k
Ivan Nestorov United States	30	463 0.9×	409 0.9×	423 1.1×	150 0.5×	623 2.6×	88	2.5k
Suhasini Iyer United States	26	1.3k 2.6×	504 1.0×	776 1.9×	230 0.8×	566 2.4×	54	2.2k
Alexander Staab Germany	23	445 0.9×	541 1.1×	146 0.4×	106 0.4×	174 0.7×	54	2.0k
Alain Munafo Switzerland	28	340 0.7×	297 0.6×	221 0.6×	118 0.4×	444 1.9×	63	1.9k
Balaji Agoram United States	18	331 0.7×	306 0.6×	154 0.4×	102 0.4×	344 1.4×	46	1.3k
Tomoo Itoh Japan	27	319 0.6×	672 1.4×	363 0.9×	157 0.5×	104 0.4×	98	2.0k
Andreas Kovar Germany	15	258 0.5×	447 0.9×	187 0.5×	79 0.3×	126 0.5×	27	1.0k
Jin Y. Jin United States	24	538 1.1×	732 1.5×	384 1.0×	67 0.2×	204 0.9×	95	1.9k
Yu Chen Barrett United States	17	696 1.4×	265 0.6×	670 1.7×	82 0.3×	894 3.7×	25	2.9k
Stacy S. Shord United States	28	714 1.4×	1.0k 2.2×	167 0.4×	159 0.5×	274 1.1×	69	2.7k

Countries citing papers authored by Chee M. Ng

Since Specialization

Citations

This map shows the geographic impact of Chee M. Ng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chee M. Ng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chee M. Ng more than expected).

Fields of papers citing papers by Chee M. Ng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chee M. Ng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chee M. Ng. The network helps show where Chee M. Ng may publish in the future.

Co-authorship network of co-authors of Chee M. Ng

This figure shows the co-authorship network connecting the top 25 collaborators of Chee M. Ng. A scholar is included among the top collaborators of Chee M. Ng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chee M. Ng. Chee M. Ng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gibiansky, Leonid, Chee M. Ng, & Ekaterina Gibiansky. (2024). Target-mediated drug disposition model for drugs with N > 2 binding sites that bind to a target with one binding site. Journal of Pharmacokinetics and Pharmacodynamics. 51(6). 703–720. 1 indexed citations

Ng, Chee M.. (2022). National Trades Union Congress (NTUC)’s Changing Role in Shaping Singapore’s Evolving Work Compact. 1(1). 60–67. 2 indexed citations

Hardiansyah, Deni & Chee M. Ng. (2022). Minimal Physiologically-based Pharmacokinetic Model to Investigate the Effect of Charge on the Pharmacokinetics of Humanized anti-HCV-E2 IgG Antibodies in Sprague–Dawley Rats. Pharmaceutical Research. 39(3). 481–496. 6 indexed citations

Tang, Fei, et al.. (2020). Using medical claims database to develop a population disease progression model for leuprorelin-treated subjects with hormone-sensitive prostate cancer. PLoS ONE. 15(3). e0230571–e0230571. 1 indexed citations

Hardiansyah, Deni & Chee M. Ng. (2018). Two-Pore Minimum Physiologically-based Pharmacokinetic Model to Describe the Disposition of Therapeutic Monoclonal IgG Antibody in Humans. Pharmaceutical Research. 35(3). 47–47. 6 indexed citations

Han, Tianxiang, Ruth Everett, William R. Proctor, et al.. (2013). Organic Cation Transporter 1 (OCT1/mOct1) Is Localized in the Apical Membrane of Caco-2 Cell Monolayers and Enterocytes. Molecular Pharmacology. 84(2). 182–189. 83 indexed citations

Zuo, Xiao‐cong, Chee M. Ng, Jeffrey S. Barrett, et al.. (2013). Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients. Pharmacogenetics and Genomics. 23(5). 251–261. 108 indexed citations

Bhatt‐Mehta, Varsha, Chee M. Ng, & Robert E. Schumacher. (2013). Effectiveness of a Clinical Pathway With Methadone Treatment Protocol for Treatment of Neonatal Abstinence Syndrome Following In Utero Drug Exposure to Substances of Abuse*. Pediatric Critical Care Medicine. 15(2). 162–169. 8 indexed citations

Choo, Edna F., Chee M. Ng, Leanne Berry, et al.. (2012). PK-PD modeling of combination efficacy effect from administration of the MEK inhibitor GDC-0973 and PI3K inhibitor GDC-0941 in A2058 xenografts. Cancer Chemotherapy and Pharmacology. 71(1). 133–143. 26 indexed citations

10.

Hsu, Yu-Han H., Gregory Z. Ferl, & Chee M. Ng. (2012). GPU-accelerated nonparametric kinetic analysis of DCE-MRI data from glioblastoma patients treated with bevacizumab. Magnetic Resonance Imaging. 31(4). 618–623. 8 indexed citations

11.

Zhang, Ping, Chee M. Ng, James F. List, & Marc Pfister. (2010). Synergy Between Scientific Advancement and Technological Innovation, Illustrated by a Mechanism‐Based Model Characterizing Sodium‐Glucose Cotransporter‐2 Inhibition. The Journal of Clinical Pharmacology. 50(S9). 113S–120S. 6 indexed citations

12.

Lin, Chia‐Chi, Muralidhar Beeram, Eric K. Rowinsky, et al.. (2009). Phase I and pharmacokinetic study of cisplatin and troxacitabine administered intravenously every 28 days in patients with advanced solid malignancies. Cancer Chemotherapy and Pharmacology. 65(1). 167–175. 2 indexed citations

13.

Ng, Chee M., Shuang Bai, Chris H. Takimoto, Meina Tang, & Anthony W. Tolcher. (2009). Mechanism-based receptor-binding model to describe the pharmacokinetic and pharmacodynamic of an anti-α5β1 integrin monoclonal antibody (volociximab) in cancer patients. Cancer Chemotherapy and Pharmacology. 65(2). 207–217. 23 indexed citations

14.

Agresti, Cristina, Zhigang Tu, Chee M. Ng, Yongsheng Yang, & Jun Liang. (2008). Specific interactions between diphenhydramine and α-helical poly(glutamic acid) – A new ion-pairing complex for taste masking and pH-controlled diphenhydramine release. European Journal of Pharmaceutics and Biopharmaceutics. 70(1). 226–233. 37 indexed citations

15.

Rodón, Jordi, Amita Patnaik, Mark N. Stein, et al.. (2007). A phase I study of q3W R1507, a human monoclonal antibody IGF-1R (insulin-like growth factor receptor) antagonist in patients with advanced solid tumors. Molecular Cancer Therapeutics. 6. 10 indexed citations

16.

Bauer, Robert J., Serge Guzy, & Chee M. Ng. (2007). A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples. The AAPS Journal. 9(1). E60–E83. 148 indexed citations

17.

Ng, Chee M., René Bruno, Dan Combs, & Brian E. Davies. (2005). Population Pharmacokinetics of Rituximab (Anti‐CD20 Monoclonal Antibody) in Rheumatoid Arthritis Patients During a Phase II Clinical Trial. The Journal of Clinical Pharmacology. 45(7). 792–801. 172 indexed citations

18.

Ng, Chee M., Eric Stefanich, Banmeet S. Anand, Paul J. Fielder, & Louis Vaickus. (2005). Pharmacokinetics/Pharmacodynamics of Nondepleting Anti-CD4 Monoclonal Antibody (TRX1) in Healthy Human Volunteers. Pharmaceutical Research. 23(1). 95–103. 85 indexed citations

19.

Ng, Chee M., Yun-De Xiao, Wendy S. Putnam, Bert L. Lum, & Alexander Tropsha. (2004). Quantitative structure−pharmacokinetic parameters relationships (QSPKR) analysis of antimicrobial agents in humans using simulated annealing k‐nearest‐neighbor and partial least‐square analysis methods**This paper was presented in part at the Annual Meeting of the American Association of Pharmaceutical Scientists in Toronto in 2003.. Journal of Pharmaceutical Sciences. 93(10). 2535–2544. 37 indexed citations

20.

Lee, Kiho, Chee M. Ng, Kim L. R. Brouwer, & Dhiren R. Thakker. (2002). Secretory Transport of Ranitidine and Famotidine across Caco-2 Cell Monolayers. Journal of Pharmacology and Experimental Therapeutics. 303(2). 574–580. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact